Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Beryl Drugs Annual General Meeting

Beryl Drugs Limited shareholders approved new director appointments and material related party transactions during the EGM. The meeting concluded successfully with all requisite majorities.

Source

BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Beryl Drugs Ltd: key numbers

Share price
₹25.85
Market cap
₹13.11 Cr
Revenue (annual)
₹18.82 Cr
Net profit (annual)
₹0.42 Cr
P/E (TTM)
21.0×Sector 46.1×
Promoter holding
27.97%+0.15% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Beryl Drugs Ltd

All →

Other annual general meeting announcements

All →